Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NIH × Has announcements × Genitourinary × Clear all

Phase

Status

Sponsor Class

INDUSTRY 42 NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 3 Sarcoma 2 Other hematologic neoplasm 2 Gynecologic 2 NET 1 Genitourinary 1 Gastrointestinal 1 Endocrine 1 Dermatologic 1 Classical hematology 1 CNS 1

Conditions

Carcinoma, Renal Cell 1

Interventions

cabozantinib 1 Sunitinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01835158 2021-02-11

Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

National Cancer Institute (NCI)

Phase 2 Completed

157 enrolled 10 charts 1 FDA

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡